News from pharmaventures A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Nov 24, 2020, 03:00 ET PharmaVentures advises GPCR Therapeutics on their acquisition of Burixafor

PharmaVentures today announced it has acted as an advisor to GPCR Therapeutics, Inc. (GPCR) providing due diligence for their acquisition of...


Jan 08, 2020, 04:00 ET PharmaVentures Strengthens its M&A and Fundraising Capabilities with the Appointment of a New Managing Director, Robert Gebhardt

PharmaVentures is pleased to announce the appointment of Robert Gebhardt as a Managing Director. Robert is an experienced investment banking...


Sep 30, 2019, 04:00 ET PharmaVentures Strengthens Its Global Reach with the Establishment of an International Advisory Board

PharmaVentures is pleased to announce the establishment of a new International Advisory Board, comprised of pharmaceutical, medical, transactional...


Sep 06, 2018, 06:45 ET PharmaVentures Advises Vital Foods on the Sale of its Zyactinase-based Digestive Health Product Asset Portfolio to Mundipharma

PharmaVentures Ltd. ("PharmaVentures") is pleased to announce that it acted as exclusive adviser to Vital Food Processors Ltd ("Vital Foods"), an...


Oct 28, 2016, 07:00 ET PharmaVentures Advises IDT Australia on the Divestment of CMAX Clinical Trial Business to the Japanese Company I'rom Group Co. Ltd.

PharmaVentures is pleased to announce that it acted as adviser to IDT Australia Limited for the successful divestment of CMAX, a dedicated clinical...


Jul 28, 2016, 05:00 ET PharmaVentures Advises the Baylor Scott & White Research Institute on Collaboration With Abzena plc and Creation of Denceptor Therapeutics

PharmaVentures is pleased to announce that it acted as an adviser to the Baylor Scott & White Research Institute in connection with the creation of...


Mar 22, 2016, 06:28 ET PharmaVentures Advises 3Legs Resources on its Acquisition of the Immuno-Oncology Company SalvaRx Who Announced its Admission for Trading on AIM Today

PharmaVentures is pleased to announce that it acted as an independent technical and commercial expert adviser to 3Legs on its Reverse Takeover of...


Feb 04, 2016, 05:00 ET PharmaVentures Advises Transgene on the Sale of Their Biopharmaceutical Manufacturing Plant

PharmaVentures is pleased to announce that it acted as an advisor to Transgene on the sale of its biopharmaceutical manufacturing unit in Strasbourg, ...


Dec 17, 2015, 04:00 ET PharmaVentures Advises Stericool on Sale to Sweden's Getinge Group

PharmaVentures is pleased to announce that it acted as advisor to Stericool on its sale to Sweden's Getinge Group, a global leader in infection...


Apr 11, 2013, 12:14 ET PharmaVentures acts as Exclusive Advisor on the Sale of a Majority Stake in Doğu Tip, a Turkish Diagnostic Imaging Services Company,to Techno Group Investment Holdings, a Gulf Capital Portfolio Company

PharmaVentures is pleased to announce that Techno Group Investment Holdings, a portfolio company of Gulf Capital, has acquired 100% of Doğu Tip, a...


Dec 19, 2012, 07:13 ET PharmaVentures Acts as Exclusive Advisor to Sanofi in the Divestment of Zentiva's Hlovovec Production Facility to Wood Pharma Holding

PharmaVentures is pleased to announce that it has acted as transaction advisors and sale process executioners for Sanofi. The current deal covers...


Oct 18, 2012, 06:41 ET Stephen Waterman Joins PharmaVentures

PharmaVentures today announced the appointment of Stephen Waterman as Vice President in its Corporate Advisory business, significantly enhancing...


Mar 21, 2012, 09:48 ET PTV Interview Exclusive: Revolutionary GSK and J&J Participation in New Index Ventures Fund

Fintan Walton talks exclusively to Johnson & Johnson (J&J) and GlaxoSmithKline (GSK) about their participation in Index Ventures' latest fund...


Jan 25, 2012, 12:25 ET Deal-making Declines by 18% in a Year as Pharmaceutical Companies Tighten Their Belt

Overall pharmaceutical deal-making activity fell by 18% in 2011 as pharmaceutical companies cut R&D expenditure and streamlined their research and...


Jan 19, 2012, 07:49 ET PharmaVentures Helps Secure Investor for Former MSD Research Site

PharmaVentures announced today that it was delighted to act as transaction advisor to MSD (operating in the US and Canada as Merck & Co) to secure...


Oct 20, 2011, 05:27 ET Pfizer, Sanofi and Genentech Feature Prominently in the Oncology Edition of PharmaDeals' New Publication Series; Essential Deal Trends

PharmaVentures today announced the launch of PharmaDeals®Essential Deal Trends: Oncology 2011. This new series of reports is essential reading for...


Oct 04, 2011, 03:00 ET PharmaVentures Appoints Andy Smith as Head of Corporate Finance

PharmaVentures today announced the appointment of Andy Smith as Head of Corporate Finance to significantly enhance Pharmaventures' advisory...


Jul 12, 2011, 03:00 ET PharmaVentures Engaged by Avexa to Assist in the Out-licensing of Apricitabine

PharmaVentures Limited, experts in deals and alliances, are pleased to announce that they have been engaged by Avexa Limited to seek an out-licensing ...


Jun 07, 2011, 02:30 ET PharmaVentures Corporate Advisory Appoints Ping Shek as Senior Director in Transactions

PharmaVentures today announced the appointment of Ping Shek as Senior Director in the Transactions division of Corporate Advisory working on a number ...


Feb 22, 2011, 02:29 ET PharmaDeals Research Reveals Early Signs of Recovery in Pharma Industry Deal Making

PharmaDeals(R) research has revealed that the early stages of recovery are now evident within pharmaceutical deal-making activity. The overall number ...


Oct 26, 2010, 06:49 ET PharmaVentures Acts as Advisor and Broker to Dr Reddy's to Identify and Secure Product Marketing Opportunities for the Russian/CIS Market

PharmaVentures Ltd announced today that it had acted as the advisor and broker to the Indian pharmaceutical company Dr Reddy's Laboratories in its...


Aug 31, 2010, 01:59 ET PharmaVentures Appoints Paul Phull as Senior Director

- New Business Development Expert Brings More Than 20 Years of Industry M&A and Licensing Experience to Strengthen Pharmaventures' Corporate Advisory ...


Aug 19, 2010, 05:37 ET As Pharmaceutical Deal Making Becomes More Competitive, PharmaDeals(R) Resource Expands its Deal Coverage

PharmaVentures, the company behind the PharmaDeals(R) range of business information, announced today the expansion of its PharmaDeals Agreements...